Florida Senate - 2026 COMMITTEE AMENDMENT
Bill No. SB 432
Ì840290ÅÎ840290
LEGISLATIVE ACTION
Senate . House
Comm: RCS .
02/24/2026 .
.
.
.
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
The Committee on Fiscal Policy (Yarborough) recommended the
following:
1 Senate Substitute for Amendment (304338) (with title
2 amendment)
3
4 Delete everything after the enacting clause
5 and insert:
6 Section 1. Section 2 of this act may be cited as “Meg’s
7 Law.”
8 Section 2. Section 569.216, Florida Statutes, is created to
9 read:
10 569.216 Prohibition on possessing, selling, furnishing, or
11 giving nitrous oxide; exceptions; penalties.—
12 (1) It is unlawful for any dealer who is licensed or
13 permitted under this chapter, or a dealer’s agent or employee,
14 to possess, sell, possess with intent to sell, deliver, or give,
15 directly or indirectly, nitrous oxide on or from the dealer’s
16 licensed premises. A dealer or a dealer’s agent or employee who
17 violates this subsection commits a felony of the third degree,
18 punishable as provided in s. 775.082, s. 775.083, or s. 775.084.
19 (2) This section does not apply to a grocery store or
20 supermarket, as licensed or permitted by the Department of
21 Agriculture and Consumer Services, but does apply to a
22 convenience business, as defined by s. 812.171.
23 (3) This section does not prohibit the purchase or sale of
24 a finished food product in which nitrous oxide is used solely as
25 a propellant.
26 (4) The Department of Business and Professional Regulation
27 shall adopt rules regarding the sale and purchase of nitrous
28 oxide to prevent the use of nitrous oxide for inducing a
29 condition of intoxication. Such rules may address products
30 containing nitrous oxide and finished food products in which
31 nitrous oxide is used solely as a propellant.
32 Section 3. Effective July 1, 2026, paragraph (c) of
33 subsection (1) of section 893.03, Florida Statutes, is amended
34 to read:
35 893.03 Standards and schedules.—The substances enumerated
36 in this section are controlled by this chapter. The controlled
37 substances listed or to be listed in Schedules I, II, III, IV,
38 and V are included by whatever official, common, usual,
39 chemical, trade name, or class designated. The provisions of
40 this section shall not be construed to include within any of the
41 schedules contained in this section any excluded drugs listed
42 within the purview of 21 C.F.R. s. 1308.22, styled “Excluded
43 Substances”; 21 C.F.R. s. 1308.24, styled “Exempt Chemical
44 Preparations”; 21 C.F.R. s. 1308.32, styled “Exempted
45 Prescription Products”; or 21 C.F.R. s. 1308.34, styled “Exempt
46 Anabolic Steroid Products.”
47 (1) SCHEDULE I.—A substance in Schedule I has a high
48 potential for abuse and has no currently accepted medical use in
49 treatment in the United States and in its use under medical
50 supervision does not meet accepted safety standards. The
51 following substances are controlled in Schedule I:
52 (c) Unless specifically excepted or unless listed in
53 another schedule, any material, compound, mixture, or
54 preparation that contains any quantity of the following
55 hallucinogenic substances or that contains any of their salts,
56 isomers, including optical, positional, or geometric isomers,
57 homologues, nitrogen-heterocyclic analogs, esters, ethers, and
58 salts of isomers, homologues, nitrogen-heterocyclic analogs,
59 esters, or ethers, if the existence of such salts, isomers, and
60 salts of isomers is possible within the specific chemical
61 designation or class description:
62 1. Alpha-Ethyltryptamine.
63 2. 4-Methylaminorex (2-Amino-4-methyl-5-phenyl-2
64 oxazoline).
65 3. Aminorex (2-Amino-5-phenyl-2-oxazoline).
66 4. DOB (4-Bromo-2,5-dimethoxyamphetamine).
67 5. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
68 6. Bufotenine.
69 7. Cannabis.
70 8. Cathinone.
71 9. DET (Diethyltryptamine).
72 10. 2,5-Dimethoxyamphetamine.
73 11. DOET (4-Ethyl-2,5-Dimethoxyamphetamine).
74 12. DMT (Dimethyltryptamine).
75 13. PCE (N-Ethyl-1-phenylcyclohexylamine) (Ethylamine
76 analog of phencyclidine).
77 14. JB-318 (N-Ethyl-3-piperidyl benzilate).
78 15. N-Ethylamphetamine.
79 16. Fenethylline.
80 17. 3,4-Methylenedioxy-N-hydroxyamphetamine.
81 18. Ibogaine.
82 19. LSD (Lysergic acid diethylamide).
83 20. Mescaline.
84 21. Methcathinone.
85 22. 5-Methoxy-3,4-methylenedioxyamphetamine.
86 23. PMA (4-Methoxyamphetamine).
87 24. PMMA (4-Methoxymethamphetamine).
88 25. DOM (4-Methyl-2,5-dimethoxyamphetamine).
89 26. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
90 27. MDA (3,4-Methylenedioxyamphetamine).
91 28. JB-336 (N-Methyl-3-piperidyl benzilate).
92 29. N,N-Dimethylamphetamine.
93 30. Parahexyl.
94 31. Peyote.
95 32. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine) (Pyrrolidine
96 analog of phencyclidine).
97 33. Psilocybin.
98 34. Psilocyn.
99 35. Salvia divinorum, except for any drug product approved
100 by the United States Food and Drug Administration which contains
101 Salvia divinorum or its isomers, esters, ethers, salts, and
102 salts of isomers, esters, and ethers, if the existence of such
103 isomers, esters, ethers, and salts is possible within the
104 specific chemical designation.
105 36. Salvinorin A, except for any drug product approved by
106 the United States Food and Drug Administration which contains
107 Salvinorin A or its isomers, esters, ethers, salts, and salts of
108 isomers, esters, and ethers, if the existence of such isomers,
109 esters, ethers, and salts is possible within the specific
110 chemical designation.
111 37. Xylazine, except for a xylazine animal drug product
112 approved by the United States Food and Drug Administration and
113 the use of which conforms to the approved application or is
114 authorized under 21 U.S.C. s. 360b(a)(4). The manufacture,
115 importation, distribution, prescribing, or sale of xylazine for
116 human use is not subject to this exception.
117 38. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)
118 (Thiophene analog of phencyclidine).
119 39. 3,4,5-Trimethoxyamphetamine.
120 40. Methylone (3,4-Methylenedioxymethcathinone).
121 41. MDPV (3,4-Methylenedioxypyrovalerone).
122 42. Methylmethcathinone.
123 43. Methoxymethcathinone.
124 44. Fluoromethcathinone.
125 45. Methylethcathinone.
126 46. CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
127 yl)phenol) and its dimethyloctyl (C8) homologue.
128 47. HU-210 [(6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2
129 methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol].
130 48. JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
131 49. JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
132 50. JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
133 naphthoyl)indole).
134 51. BZP (Benzylpiperazine).
135 52. Fluorophenylpiperazine.
136 53. Methylphenylpiperazine.
137 54. Chlorophenylpiperazine.
138 55. Methoxyphenylpiperazine.
139 56. DBZP (1,4-Dibenzylpiperazine).
140 57. TFMPP (Trifluoromethylphenylpiperazine).
141 58. MBDB (Methylbenzodioxolylbutanamine) or (3,4
142 Methylenedioxy-N-methylbutanamine).
143 59. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
144 60. 5-Hydroxy-N-methyltryptamine.
145 61. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
146 62. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
147 63. Methyltryptamine.
148 64. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
149 65. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
150 66. Tyramine (4-Hydroxyphenethylamine).
151 67. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
152 68. DiPT (N,N-Diisopropyltryptamine).
153 69. DPT (N,N-Dipropyltryptamine).
154 70. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
155 71. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
156 72. DOI (4-Iodo-2,5-dimethoxyamphetamine).
157 73. DOC (4-Chloro-2,5-dimethoxyamphetamine).
158 74. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
159 75. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
160 76. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
161 77. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
162 78. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
163 79. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
164 80. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
165 81. Butylone (3,4-Methylenedioxy-alpha
166 methylaminobutyrophenone).
167 82. Ethcathinone.
168 83. Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
169 84. Naphyrone (Naphthylpyrovalerone).
170 85. Dimethylone (3,4-Methylenedioxy-N,N-dimethylcathinone).
171 86. 3,4-Methylenedioxy-N,N-diethylcathinone.
172 87. 3,4-Methylenedioxy-propiophenone.
173 88. 3,4-Methylenedioxy-alpha-bromopropiophenone.
174 89. 3,4-Methylenedioxy-propiophenone-2-oxime.
175 90. 3,4-Methylenedioxy-N-acetylcathinone.
176 91. 3,4-Methylenedioxy-N-acetylmethcathinone.
177 92. 3,4-Methylenedioxy-N-acetylethcathinone.
178 93. Bromomethcathinone.
179 94. Buphedrone (alpha-Methylamino-butyrophenone).
180 95. Eutylone (3,4-Methylenedioxy-alpha
181 ethylaminobutyrophenone).
182 96. Dimethylcathinone.
183 97. Dimethylmethcathinone.
184 98. Pentylone (3,4-Methylenedioxy-alpha
185 methylaminovalerophenone).
186 99. MDPPP (3,4-Methylenedioxy-alpha
187 pyrrolidinopropiophenone).
188 100. MDPBP (3,4-Methylenedioxy-alpha
189 pyrrolidinobutyrophenone).
190 101. MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
191 102. MPHP (Methyl-alpha-pyrrolidinohexanophenone).
192 103. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
193 (Benocyclidine).
194 104. F-MABP (Fluoromethylaminobutyrophenone).
195 105. MeO-PBP (Methoxypyrrolidinobutyrophenone).
196 106. Et-PBP (Ethylpyrrolidinobutyrophenone).
197 107. 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
198 108. Me-EABP (Methylethylaminobutyrophenone).
199 109. Etizolam.
200 110. PPP (Pyrrolidinopropiophenone).
201 111. PBP (Pyrrolidinobutyrophenone).
202 112. PVP (Pyrrolidinovalerophenone) or
203 (Pyrrolidinopentiophenone).
204 113. MPPP (Methyl-alpha-pyrrolidinopropiophenone).
205 114. JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
206 115. JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
207 116. JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
208 117. JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
209 118. JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
210 119. JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
211 120. JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
212 121. JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
213 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
214 122. JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
215 123. JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
216 124. JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
217 125. JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
218 126. JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
219 127. JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
220 128. JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
221 129. JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
222 130. HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
223 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
224 ol).
225 131. HU-308 ([(1R,2R,5R)-2-[2,6-Dimethoxy-4-(2-methyloctan
226 2-yl)phenyl]-7,7-dimethyl-4-bicyclo[3.1.1]hept-3-enyl]
227 methanol).
228 132. HU-331 (3-Hydroxy-2-[(1R,6R)-3-methyl-6-(1
229 methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene
230 1,4-dione).
231 133. CB-13 (4-Pentyloxy-1-(1-naphthoyl)naphthalene).
232 134. CB-25 (N-Cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)
233 undecanamide).
234 135. CB-52 (N-Cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)
235 undecanamide).
236 136. CP 55,940 (2-[3-Hydroxy-6-propanol-cyclohexyl]-5-(2
237 methyloctan-2-yl)phenol).
238 137. AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
239 138. AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indole).
240 139. RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
241 140. RCS-8 (1-(2-Cyclohexylethyl)-3-(2
242 methoxyphenylacetyl)indole).
243 141. WIN55,212-2 ((R)-(+)-[2,3-Dihydro-5-methyl-3-(4
244 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
245 naphthalenylmethanone).
246 142. WIN55,212-3 ([(3S)-2,3-Dihydro-5-methyl-3-(4
247 morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1
248 naphthalenylmethanone).
249 143. Pentedrone (alpha-Methylaminovalerophenone).
250 144. Fluoroamphetamine.
251 145. Fluoromethamphetamine.
252 146. Methoxetamine.
253 147. Methiopropamine.
254 148. Methylbuphedrone (Methyl-alpha
255 methylaminobutyrophenone).
256 149. APB ((2-Aminopropyl)benzofuran).
257 150. APDB ((2-Aminopropyl)-2,3-dihydrobenzofuran).
258 151. UR-144 (1-Pentyl-3-(2,2,3,3
259 tetramethylcyclopropanoyl)indole).
260 152. XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
261 tetramethylcyclopropanoyl)indole).
262 153. Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
263 tetramethylcyclopropanoyl)indole).
264 154. AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
265 155. AM-2233(1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
266 iodobenzoyl)indole).
267 156. STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
268 carboxamide).
269 157. URB-597 ((3′-(Aminocarbonyl)[1,1′-biphenyl]-3-yl)
270 cyclohexylcarbamate).
271 158. URB-602 ([1,1′-Biphenyl]-3-yl-carbamic acid,
272 cyclohexyl ester).
273 159. URB-754 (6-Methyl-2-[(4-methylphenyl)amino]-1
274 benzoxazin-4-one).
275 160. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
276 161. 2C-H (2,5-Dimethoxyphenethylamine).
277 162. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
278 163. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
279 164. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
280 methoxybenzyl)]phenethylamine).
281 165. MDMA (3,4-Methylenedioxymethamphetamine).
282 166. PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
283 167. Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
284 carboxylate).
285 168. BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
286 carboxylate).
287 169. Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
288 3-carboxamide).
289 170. AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
290 pentylindazole-3-carboxamide).
291 171. AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
292 (4-fluorobenzyl)indazole-3-carboxamide).
293 172. ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
294 1-pentylindazole-3-carboxamide).
295 173. Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
296 yl)-1-(fluoropentyl)indole-3-carboxamide).
297 174. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
298 methoxybenzyl)]phenethylamine).
299 175. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
300 methoxybenzyl)]phenethylamine).
301 176. AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
302 (cyclohexylmethyl)indazole-3-carboxamide).
303 177. FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
304 carboxylate).
305 178. Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
306 3-carboxamide).
307 179. Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
308 (fluoropentyl)indazole-3-carboxamide).
309 180. THJ-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl)indazole).
310 181. AM-855 ((4aR,12bR)-8-Hexyl-2,5,5-trimethyl
311 1,4,4a,8,9,10,11,12b-octahydronaphtho[3,2-c]isochromen-12-ol).
312 182. AM-905 ((6aR,9R,10aR)-3-[(E)-Hept-1-enyl]-9
313 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
314 hexahydrobenzo[c]chromen-1-ol).
315 183. AM-906 ((6aR,9R,10aR)-3-[(Z)-Hept-1-enyl]-9
316 (hydroxymethyl)-6,6-dimethyl-6a,7,8,9,10,10a
317 hexahydrobenzo[c]chromen-1-ol).
318 184. AM-2389 ((6aR,9R,10aR)-3-(1-Hexyl-cyclobut-1-yl)
319 6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9
320 diol).
321 185. HU-243 ((6aR,8S,9S,10aR)-9-(Hydroxymethyl)-6,6
322 dimethyl-3-(2-methyloctan-2-yl)-8,9-ditritio-7,8,10,10a
323 tetrahydro-6aH-benzo[c]chromen-1-ol).
324 186. HU-336 ((6aR,10aR)-6,6,9-Trimethyl-3-pentyl
325 6a,7,10,10a-tetrahydro-1H-benzo[c]chromene-1,4(6H)-dione).
326 187. MAPB ((2-Methylaminopropyl)benzofuran).
327 188. 5-IT (2-(1H-Indol-5-yl)-1-methyl-ethylamine).
328 189. 6-IT (2-(1H-Indol-6-yl)-1-methyl-ethylamine).
329 190. Synthetic Cannabinoids.—Unless specifically excepted
330 or unless listed in another schedule or contained within a
331 pharmaceutical product approved by the United States Food and
332 Drug Administration, any material, compound, mixture, or
333 preparation that contains any quantity of a synthetic
334 cannabinoid found to be in any of the following chemical class
335 descriptions, or homologues, nitrogen-heterocyclic analogs,
336 isomers (including optical, positional, or geometric), esters,
337 ethers, salts, and salts of homologues, nitrogen-heterocyclic
338 analogs, isomers, esters, or ethers, whenever the existence of
339 such homologues, nitrogen-heterocyclic analogs, isomers, esters,
340 ethers, salts, and salts of isomers, esters, or ethers is
341 possible within the specific chemical class or designation.
342 Since nomenclature of these synthetically produced cannabinoids
343 is not internationally standardized and may continually evolve,
344 these structures or the compounds of these structures shall be
345 included under this subparagraph, regardless of their specific
346 numerical designation of atomic positions covered, if it can be
347 determined through a recognized method of scientific testing or
348 analysis that the substance contains properties that fit within
349 one or more of the following categories:
350 a. Tetrahydrocannabinols.—Any tetrahydrocannabinols
351 naturally contained in a plant of the genus Cannabis, the
352 synthetic equivalents of the substances contained in the plant
353 or in the resinous extracts of the genus Cannabis, or synthetic
354 substances, derivatives, and their isomers with similar chemical
355 structure and pharmacological activity, including, but not
356 limited to, Delta 9 tetrahydrocannabinols and their optical
357 isomers, Delta 8 tetrahydrocannabinols and their optical
358 isomers, Delta 6a,10a tetrahydrocannabinols and their optical
359 isomers, or any compound containing a tetrahydrobenzo[c]chromene
360 structure with substitution at either or both the 3-position or
361 9-position, with or without substitution at the 1-position with
362 hydroxyl or alkoxy groups, including, but not limited to:
363 (I) Tetrahydrocannabinol.
364 (II) HU-210 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
365 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
366 ol).
367 (III) HU-211 ((6aS,10aS)-9-(Hydroxymethyl)-6,6-dimethyl-3
368 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1
369 ol).
370 (IV) JWH-051 ((6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3
371 (2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
372 (V) JWH-133 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methylpentan
373 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
374 (VI) JWH-057 ((6aR,10aR)-6,6,9-Trimethyl-3-(2-methyloctan
375 2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
376 (VII) JWH-359 ((6aR,10aR)-1-Methoxy-6,6,9-trimethyl-3-(2,3
377 dimethylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene).
378 (VIII) AM-087 ((6aR,10aR)-3-(2-Methyl-6-bromohex-2-yl)
379 6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
380 (IX) AM-411 ((6aR,10aR)-3-(1-Adamantyl)-6,6,9-trimethyl
381 6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol).
382 (X) Parahexyl.
383 b. Naphthoylindoles, Naphthoylindazoles,
384 Naphthoylcarbazoles, Naphthylmethylindoles,
385 Naphthylmethylindazoles, and Naphthylmethylcarbazoles.—Any
386 compound containing a naphthoylindole, naphthoylindazole,
387 naphthoylcarbazole, naphthylmethylindole,
388 naphthylmethylindazole, or naphthylmethylcarbazole structure,
389 with or without substitution on the indole, indazole, or
390 carbazole ring to any extent, whether or not substituted on the
391 naphthyl ring to any extent, including, but not limited to:
392 (I) JWH-007 (1-Pentyl-2-methyl-3-(1-naphthoyl)indole).
393 (II) JWH-011 (1-(1-Methylhexyl)-2-methyl-3-(1
394 naphthoyl)indole).
395 (III) JWH-015 (1-Propyl-2-methyl-3-(1-naphthoyl)indole).
396 (IV) JWH-016 (1-Butyl-2-methyl-3-(1-naphthoyl)indole).
397 (V) JWH-018 (1-Pentyl-3-(1-naphthoyl)indole).
398 (VI) JWH-019 (1-Hexyl-3-(1-naphthoyl)indole).
399 (VII) JWH-020 (1-Heptyl-3-(1-naphthoyl)indole).
400 (VIII) JWH-022 (1-(4-Pentenyl)-3-(1-naphthoyl)indole).
401 (IX) JWH-071 (1-Ethyl-3-(1-naphthoyl)indole).
402 (X) JWH-072 (1-Propyl-3-(1-naphthoyl)indole).
403 (XI) JWH-073 (1-Butyl-3-(1-naphthoyl)indole).
404 (XII) JWH-080 (1-Butyl-3-(4-methoxy-1-naphthoyl)indole).
405 (XIII) JWH-081 (1-Pentyl-3-(4-methoxy-1-naphthoyl)indole).
406 (XIV) JWH-098 (1-Pentyl-2-methyl-3-(4-methoxy-1
407 naphthoyl)indole).
408 (XV) JWH-116 (1-Pentyl-2-ethyl-3-(1-naphthoyl)indole).
409 (XVI) JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole).
410 (XVII) JWH-149 (1-Pentyl-2-methyl-3-(4-methyl-1
411 naphthoyl)indole).
412 (XVIII) JWH-164 (1-Pentyl-3-(7-methoxy-1-naphthoyl)indole).
413 (XIX) JWH-175 (1-Pentyl-3-(1-naphthylmethyl)indole).
414 (XX) JWH-180 (1-Propyl-3-(4-propyl-1-naphthoyl)indole).
415 (XXI) JWH-182 (1-Pentyl-3-(4-propyl-1-naphthoyl)indole).
416 (XXII) JWH-184 (1-Pentyl-3-[(4-methyl)-1
417 naphthylmethyl]indole).
418 (XXIII) JWH-193 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methyl-1
419 naphthoyl)indole).
420 (XXIV) JWH-198 (1-[2-(4-Morpholinyl)ethyl]-3-(4-methoxy-1
421 naphthoyl)indole).
422 (XXV) JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1
423 naphthoyl)indole).
424 (XXVI) JWH-210 (1-Pentyl-3-(4-ethyl-1-naphthoyl)indole).
425 (XXVII) JWH-387 (1-Pentyl-3-(4-bromo-1-naphthoyl)indole).
426 (XXVIII) JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole).
427 (XXIX) JWH-412 (1-Pentyl-3-(4-fluoro-1-naphthoyl)indole).
428 (XXX) JWH-424 (1-Pentyl-3-(8-bromo-1-naphthoyl)indole).
429 (XXXI) AM-1220 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(1
430 naphthoyl)indole).
431 (XXXII) AM-1235 (1-(5-Fluoropentyl)-6-nitro-3-(1
432 naphthoyl)indole).
433 (XXXIII) AM-2201 (1-(5-Fluoropentyl)-3-(1
434 naphthoyl)indole).
435 (XXXIV) Chloro JWH-018 (1-(Chloropentyl)-3-(1
436 naphthoyl)indole).
437 (XXXV) Bromo JWH-018 (1-(Bromopentyl)-3-(1
438 naphthoyl)indole).
439 (XXXVI) AM-2232 (1-(4-Cyanobutyl)-3-(1-naphthoyl)indole).
440 (XXXVII) THJ-2201 (1-(5-Fluoropentyl)-3-(1
441 naphthoyl)indazole).
442 (XXXVIII) MAM-2201 (1-(5-Fluoropentyl)-3-(4-methyl-1
443 naphthoyl)indole).
444 (XXXIX) EAM-2201 (1-(5-Fluoropentyl)-3-(4-ethyl-1
445 naphthoyl)indole).
446 (XL) EG-018 (9-Pentyl-3-(1-naphthoyl)carbazole).
447 (XLI) EG-2201 (9-(5-Fluoropentyl)-3-(1
448 naphthoyl)carbazole).
449 c. Naphthoylpyrroles.—Any compound containing a
450 naphthoylpyrrole structure, with or without substitution on the
451 pyrrole ring to any extent, whether or not substituted on the
452 naphthyl ring to any extent, including, but not limited to:
453 (I) JWH-030 (1-Pentyl-3-(1-naphthoyl)pyrrole).
454 (II) JWH-031 (1-Hexyl-3-(1-naphthoyl)pyrrole).
455 (III) JWH-145 (1-Pentyl-5-phenyl-3-(1-naphthoyl)pyrrole).
456 (IV) JWH-146 (1-Heptyl-5-phenyl-3-(1-naphthoyl)pyrrole).
457 (V) JWH-147 (1-Hexyl-5-phenyl-3-(1-naphthoyl)pyrrole).
458 (VI) JWH-307 (1-Pentyl-5-(2-fluorophenyl)-3-(1
459 naphthoyl)pyrrole).
460 (VII) JWH-309 (1-Pentyl-5-(1-naphthalenyl)-3-(1
461 naphthoyl)pyrrole).
462 (VIII) JWH-368 (1-Pentyl-5-(3-fluorophenyl)-3-(1
463 naphthoyl)pyrrole).
464 (IX) JWH-369 (1-Pentyl-5-(2-chlorophenyl)-3-(1
465 naphthoyl)pyrrole).
466 (X) JWH-370 (1-Pentyl-5-(2-methylphenyl)-3-(1
467 naphthoyl)pyrrole).
468 d. Naphthylmethylenindenes.—Any compound containing a
469 naphthylmethylenindene structure, with or without substitution
470 at the 3-position of the indene ring to any extent, whether or
471 not substituted on the naphthyl ring to any extent, including,
472 but not limited to, JWH-176 (3-Pentyl-1
473 (naphthylmethylene)indene).
474 e. Phenylacetylindoles and Phenylacetylindazoles.—Any
475 compound containing a phenylacetylindole or phenylacetylindazole
476 structure, with or without substitution on the indole or
477 indazole ring to any extent, whether or not substituted on the
478 phenyl ring to any extent, including, but not limited to:
479 (I) JWH-167 (1-Pentyl-3-(phenylacetyl)indole).
480 (II) JWH-201 (1-Pentyl-3-(4-methoxyphenylacetyl)indole).
481 (III) JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole).
482 (IV) JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole).
483 (V) JWH-251 (1-Pentyl-3-(2-methylphenylacetyl)indole).
484 (VI) JWH-302 (1-Pentyl-3-(3-methoxyphenylacetyl)indole).
485 (VII) Cannabipiperidiethanone.
486 (VIII) RCS-8 (1-(2-Cyclohexylethyl)-3-(2
487 methoxyphenylacetyl)indole).
488 f. Cyclohexylphenols.—Any compound containing a
489 cyclohexylphenol structure, with or without substitution at the
490 5-position of the phenolic ring to any extent, whether or not
491 substituted on the cyclohexyl ring to any extent, including, but
492 not limited to:
493 (I) CP 47,497 (2-(3-Hydroxycyclohexyl)-5-(2-methyloctan-2
494 yl)phenol).
495 (II) Cannabicyclohexanol (CP 47,497 dimethyloctyl (C8)
496 homologue).
497 (III) CP-55,940 (2-(3-Hydroxy-6-propanol-cyclohexyl)-5-(2
498 methyloctan-2-yl)phenol).
499 g. Benzoylindoles and Benzoylindazoles.—Any compound
500 containing a benzoylindole or benzoylindazole structure, with or
501 without substitution on the indole or indazole ring to any
502 extent, whether or not substituted on the phenyl ring to any
503 extent, including, but not limited to:
504 (I) AM-679 (1-Pentyl-3-(2-iodobenzoyl)indole).
505 (II) AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl)indole).
506 (III) AM-1241 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
507 iodo-5-nitrobenzoyl)indole).
508 (IV) Pravadoline (1-[2-(4-Morpholinyl)ethyl]-2-methyl-3-(4
509 methoxybenzoyl)indole).
510 (V) AM-2233 (1-[(N-Methyl-2-piperidinyl)methyl]-3-(2
511 iodobenzoyl)indole).
512 (VI) RCS-4 (1-Pentyl-3-(4-methoxybenzoyl)indole).
513 (VII) RCS-4 C4 homologue (1-Butyl-3-(4
514 methoxybenzoyl)indole).
515 (VIII) AM-630 (1-[2-(4-Morpholinyl)ethyl]-2-methyl-6-iodo
516 3-(4-methoxybenzoyl)indole).
517 h. Tetramethylcyclopropanoylindoles and
518 Tetramethylcyclopropanoylindazoles.—Any compound containing a
519 tetramethylcyclopropanoylindole or
520 tetramethylcyclopropanoylindazole structure, with or without
521 substitution on the indole or indazole ring to any extent,
522 whether or not substituted on the tetramethylcyclopropyl group
523 to any extent, including, but not limited to:
524 (I) UR-144 (1-Pentyl-3-(2,2,3,3
525 tetramethylcyclopropanoyl)indole).
526 (II) XLR11 (1-(5-Fluoropentyl)-3-(2,2,3,3
527 tetramethylcyclopropanoyl)indole).
528 (III) Chloro UR-144 (1-(Chloropentyl)-3-(2,2,3,3
529 tetramethylcyclopropanoyl)indole).
530 (IV) A-796,260 (1-[2-(4-Morpholinyl)ethyl]-3-(2,2,3,3
531 tetramethylcyclopropanoyl)indole).
532 (V) A-834,735 (1-[4-(Tetrahydropyranyl)methyl]-3-(2,2,3,3
533 tetramethylcyclopropanoyl)indole).
534 (VI) M-144 (1-(5-Fluoropentyl)-2-methyl-3-(2,2,3,3
535 tetramethylcyclopropanoyl)indole).
536 (VII) FUB-144 (1-(4-Fluorobenzyl)-3-(2,2,3,3
537 tetramethylcyclopropanoyl)indole).
538 (VIII) FAB-144 (1-(5-Fluoropentyl)-3-(2,2,3,3
539 tetramethylcyclopropanoyl)indazole).
540 (IX) XLR12 (1-(4,4,4-Trifluorobutyl)-3-(2,2,3,3
541 tetramethylcyclopropanoyl)indole).
542 (X) AB-005 (1-[(1-Methyl-2-piperidinyl)methyl]-3-(2,2,3,3
543 tetramethylcyclopropanoyl)indole).
544 i. Adamantoylindoles, Adamantoylindazoles, Adamantylindole
545 carboxamides, and Adamantylindazole carboxamides.—Any compound
546 containing an adamantoyl indole, adamantoyl indazole, adamantyl
547 indole carboxamide, or adamantyl indazole carboxamide structure,
548 with or without substitution on the indole or indazole ring to
549 any extent, whether or not substituted on the adamantyl ring to
550 any extent, including, but not limited to:
551 (I) AKB48 (N-Adamant-1-yl 1-pentylindazole-3-carboxamide).
552 (II) Fluoro AKB48 (N-Adamant-1-yl 1-(fluoropentyl)indazole
553 3-carboxamide).
554 (III) STS-135 (N-Adamant-1-yl 1-(5-fluoropentyl)indole-3
555 carboxamide).
556 (IV) AM-1248 (1-(1-Methylpiperidine)methyl-3-(1
557 adamantoyl)indole).
558 (V) AB-001 (1-Pentyl-3-(1-adamantoyl)indole).
559 (VI) APICA (N-Adamant-1-yl 1-pentylindole-3-carboxamide).
560 (VII) Fluoro AB-001 (1-(Fluoropentyl)-3-(1
561 adamantoyl)indole).
562 j. Quinolinylindolecarboxylates,
563 Quinolinylindazolecarboxylates, Quinolinylindolecarboxamides,
564 and Quinolinylindazolecarboxamides.—Any compound containing a
565 quinolinylindole carboxylate, quinolinylindazole carboxylate,
566 isoquinolinylindole carboxylate, isoquinolinylindazole
567 carboxylate, quinolinylindole carboxamide, quinolinylindazole
568 carboxamide, isoquinolinylindole carboxamide, or
569 isoquinolinylindazole carboxamide structure, with or without
570 substitution on the indole or indazole ring to any extent,
571 whether or not substituted on the quinoline or isoquinoline ring
572 to any extent, including, but not limited to:
573 (I) PB-22 (8-Quinolinyl 1-pentylindole-3-carboxylate).
574 (II) Fluoro PB-22 (8-Quinolinyl 1-(fluoropentyl)indole-3
575 carboxylate).
576 (III) BB-22 (8-Quinolinyl 1-(cyclohexylmethyl)indole-3
577 carboxylate).
578 (IV) FUB-PB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indole-3
579 carboxylate).
580 (V) NPB-22 (8-Quinolinyl 1-pentylindazole-3-carboxylate).
581 (VI) Fluoro NPB-22 (8-Quinolinyl 1-(fluoropentyl)indazole
582 3-carboxylate).
583 (VII) FUB-NPB-22 (8-Quinolinyl 1-(4-fluorobenzyl)indazole
584 3-carboxylate).
585 (VIII) THJ (8-Quinolinyl 1-pentylindazole-3-carboxamide).
586 (IX) Fluoro THJ (8-Quinolinyl 1-(fluoropentyl)indazole-3
587 carboxamide).
588 k. Naphthylindolecarboxylates and
589 Naphthylindazolecarboxylates.—Any compound containing a
590 naphthylindole carboxylate or naphthylindazole carboxylate
591 structure, with or without substitution on the indole or
592 indazole ring to any extent, whether or not substituted on the
593 naphthyl ring to any extent, including, but not limited to:
594 (I) NM-2201 (1-Naphthalenyl 1-(5-fluoropentyl)indole-3
595 carboxylate).
596 (II) SDB-005 (1-Naphthalenyl 1-pentylindazole-3
597 carboxylate).
598 (III) Fluoro SDB-005 (1-Naphthalenyl 1
599 (fluoropentyl)indazole-3-carboxylate).
600 (IV) FDU-PB-22 (1-Naphthalenyl 1-(4-fluorobenzyl)indole-3
601 carboxylate).
602 (V) 3-CAF (2-Naphthalenyl 1-(2-fluorophenyl)indazole-3
603 carboxylate).
604 l. Naphthylindole carboxamides and Naphthylindazole
605 carboxamides.—Any compound containing a naphthylindole
606 carboxamide or naphthylindazole carboxamide structure, with or
607 without substitution on the indole or indazole ring to any
608 extent, whether or not substituted on the naphthyl ring to any
609 extent, including, but not limited to:
610 (I) NNEI (N-Naphthalen-1-yl 1-pentylindole-3-carboxamide).
611 (II) Fluoro-NNEI (N-Naphthalen-1-yl 1-(fluoropentyl)indole
612 3-carboxamide).
613 (III) Chloro-NNEI (N-Naphthalen-1-yl 1
614 (chloropentyl)indole-3-carboxamide).
615 (IV) MN-18 (N-Naphthalen-1-yl 1-pentylindazole-3
616 carboxamide).
617 (V) Fluoro MN-18 (N-Naphthalen-1-yl 1
618 (fluoropentyl)indazole-3-carboxamide).
619 m. Alkylcarbonyl indole carboxamides, Alkylcarbonyl
620 indazole carboxamides, Alkylcarbonyl indole carboxylates, and
621 Alkylcarbonyl indazole carboxylates.—Any compound containing an
622 alkylcarbonyl group, including 1-amino-3-methyl-1-oxobutan-2-yl,
623 1-methoxy-3-methyl-1-oxobutan-2-yl, 1-amino-1-oxo-3
624 phenylpropan-2-yl, 1-methoxy-1-oxo-3-phenylpropan-2-yl, with an
625 indole carboxamide, indazole carboxamide, indole carboxylate, or
626 indazole carboxylate, with or without substitution on the indole
627 or indazole ring to any extent, whether or not substituted on
628 the alkylcarbonyl group to any extent, including, but not
629 limited to:
630 (I) ADBICA, (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1
631 pentylindole-3-carboxamide).
632 (II) Fluoro ADBICA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
633 yl)-1-(fluoropentyl)indole-3-carboxamide).
634 (III) Fluoro ABICA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
635 (fluoropentyl)indole-3-carboxamide).
636 (IV) AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
637 pentylindazole-3-carboxamide).
638 (V) Fluoro AB-PINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)
639 1-(fluoropentyl)indazole-3-carboxamide).
640 (VI) ADB-PINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)
641 1-pentylindazole-3-carboxamide).
642 (VII) Fluoro ADB-PINACA (N-(1-Amino-3,3-dimethyl-1
643 oxobutan-2-yl)-1-(fluoropentyl)indazole-3-carboxamide).
644 (VIII) AB-FUBINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
645 (4-fluorobenzyl)indazole-3-carboxamide).
646 (IX) ADB-FUBINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
647 yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
648 (X) AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1
649 (cyclohexylmethyl)indazole-3-carboxamide).
650 (XI) MA-CHMINACA (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
651 (cyclohexylmethyl)indazole-3-carboxamide).
652 (XII) MAB-CHMINACA (N-(1-Amino-3,3-dimethyl-1-oxobutan-2
653 yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
654 (XIII) AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
655 pentylindazole-3-carboxamide).
656 (XIV) Fluoro-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1
657 (fluoropentyl)indazole-3-carboxamide).
658 (XV) FUB-AMB (N-(1-Methoxy-3-methyl-1-oxobutan-2-yl)-1-(4
659 fluorobenzyl)indazole-3-carboxamide).
660 (XVI) MDMB-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
661 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxamide).
662 (XVII) MDMB-FUBINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
663 2-yl)-1-(4-fluorobenzyl)indazole-3-carboxamide).
664 (XVIII) MDMB-CHMICA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
665 2-yl)-1-(cyclohexylmethyl)indole-3-carboxamide).
666 (XIX) PX-1 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
667 fluoropentyl)indole-3-carboxamide).
668 (XX) PX-2 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(5
669 fluoropentyl)indazole-3-carboxamide).
670 (XXI) PX-3 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1
671 (cyclohexylmethyl)indazole-3-carboxamide).
672 (XXII) PX-4 (N-(1-Amino-1-oxo-3-phenylpropan-2-yl)-1-(4
673 fluorobenzyl)indazole-3-carboxamide).
674 (XXIII) MO-CHMINACA (N-(1-Methoxy-3,3-dimethyl-1-oxobutan
675 2-yl)-1-(cyclohexylmethyl)indazole-3-carboxylate).
676 n. Cumylindolecarboxamides and Cumylindazolecarboxamides.
677 Any compound containing a N-(2-phenylpropan-2-yl) indole
678 carboxamide or N-(2-phenylpropan-2-yl) indazole carboxamide
679 structure, with or without substitution on the indole or
680 indazole ring to any extent, whether or not substituted on the
681 phenyl ring of the cumyl group to any extent, including, but not
682 limited to:
683 (I) CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1-pentylindole-3
684 carboxamide).
685 (II) Fluoro CUMYL-PICA (N-(2-Phenylpropan-2-yl)-1
686 (fluoropentyl)indole-3-carboxamide).
687 o. Other Synthetic Cannabinoids.—Any material, compound,
688 mixture, or preparation that contains any quantity of a
689 Synthetic Cannabinoid, as described in sub-subparagraphs a.-n.:
690 (I) With or without modification or replacement of a
691 carbonyl, carboxamide, alkylene, alkyl, or carboxylate linkage
692 between either two core rings, or linkage between a core ring
693 and group structure, with or without the addition of a carbon or
694 replacement of a carbon;
695 (II) With or without replacement of a core ring or group
696 structure, whether or not substituted on the ring or group
697 structures to any extent; and
698 (III) Is a cannabinoid receptor agonist, unless
699 specifically excepted or unless listed in another schedule or
700 contained within a pharmaceutical product approved by the United
701 States Food and Drug Administration.
702 191. Substituted Cathinones.—Unless specifically excepted,
703 listed in another schedule, or contained within a pharmaceutical
704 product approved by the United States Food and Drug
705 Administration, any material, compound, mixture, or preparation,
706 including its salts, isomers, esters, or ethers, and salts of
707 isomers, esters, or ethers, whenever the existence of such salts
708 is possible within any of the following specific chemical
709 designations:
710 a. Any compound containing a 2-amino-1-phenyl-1-propanone
711 structure;
712 b. Any compound containing a 2-amino-1-naphthyl-1-propanone
713 structure; or
714 c. Any compound containing a 2-amino-1-thiophenyl-1
715 propanone structure,
716
717 whether or not the compound is further modified:
718 (I) With or without substitution on the ring system to any
719 extent with alkyl, alkylthio, thio, fused alkylenedioxy, alkoxy,
720 haloalkyl, hydroxyl, nitro, fused furan, fused benzofuran, fused
721 dihydrofuran, fused tetrahydropyran, fused alkyl ring, or halide
722 substituents;
723 (II) With or without substitution at the 3-propanone
724 position with an alkyl substituent or removal of the methyl
725 group at the 3-propanone position;
726 (III) With or without substitution at the 2-amino nitrogen
727 atom with alkyl, dialkyl, acetyl, or benzyl groups, whether or
728 not further substituted in the ring system; or
729 (IV) With or without inclusion of the 2-amino nitrogen atom
730 in a cyclic structure, including, but not limited to:
731 (A) Methcathinone.
732 (B) Ethcathinone.
733 (C) Methylone (3,4-Methylenedioxymethcathinone).
734 (D) 2,3-Methylenedioxymethcathinone.
735 (E) MDPV (3,4-Methylenedioxypyrovalerone).
736 (F) Methylmethcathinone.
737 (G) Methoxymethcathinone.
738 (H) Fluoromethcathinone.
739 (I) Methylethcathinone.
740 (J) Butylone (3,4-Methylenedioxy-alpha
741 methylaminobutyrophenone).
742 (K) Ethylone (3,4-Methylenedioxy-N-ethylcathinone).
743 (L) BMDP (3,4-Methylenedioxy-N-benzylcathinone).
744 (M) Naphyrone (Naphthylpyrovalerone).
745 (N) Bromomethcathinone.
746 (O) Buphedrone (alpha-Methylaminobutyrophenone).
747 (P) Eutylone (3,4-Methylenedioxy-alpha
748 ethylaminobutyrophenone).
749 (Q) Dimethylcathinone.
750 (R) Dimethylmethcathinone.
751 (S) Pentylone (3,4-Methylenedioxy-alpha
752 methylaminovalerophenone).
753 (T) Pentedrone (alpha-Methylaminovalerophenone).
754 (U) MDPPP (3,4-Methylenedioxy-alpha
755 pyrrolidinopropiophenone).
756 (V) MDPBP (3,4-Methylenedioxy-alpha
757 pyrrolidinobutyrophenone).
758 (W) MPPP (Methyl-alpha-pyrrolidinopropiophenone).
759 (X) PPP (Pyrrolidinopropiophenone).
760 (Y) PVP (Pyrrolidinovalerophenone) or
761 (Pyrrolidinopentiophenone).
762 (Z) MOPPP (Methoxy-alpha-pyrrolidinopropiophenone).
763 (AA) MPHP (Methyl-alpha-pyrrolidinohexanophenone).
764 (BB) F-MABP (Fluoromethylaminobutyrophenone).
765 (CC) Me-EABP (Methylethylaminobutyrophenone).
766 (DD) PBP (Pyrrolidinobutyrophenone).
767 (EE) MeO-PBP (Methoxypyrrolidinobutyrophenone).
768 (FF) Et-PBP (Ethylpyrrolidinobutyrophenone).
769 (GG) 3-Me-4-MeO-MCAT (3-Methyl-4-Methoxymethcathinone).
770 (HH) Dimethylone (3,4-Methylenedioxy-N,N
771 dimethylcathinone).
772 (II) 3,4-Methylenedioxy-N,N-diethylcathinone.
773 (JJ) 3,4-Methylenedioxy-N-acetylcathinone.
774 (KK) 3,4-Methylenedioxy-N-acetylmethcathinone.
775 (LL) 3,4-Methylenedioxy-N-acetylethcathinone.
776 (MM) Methylbuphedrone (Methyl-alpha
777 methylaminobutyrophenone).
778 (NN) Methyl-alpha-methylaminohexanophenone.
779 (OO) N-Ethyl-N-methylcathinone.
780 (PP) PHP (Pyrrolidinohexanophenone).
781 (QQ) PV8 (Pyrrolidinoheptanophenone).
782 (RR) Chloromethcathinone.
783 (SS) 4-Bromo-2,5-dimethoxy-alpha-aminoacetophenone.
784 192. Substituted Phenethylamines.—Unless specifically
785 excepted or unless listed in another schedule, or contained
786 within a pharmaceutical product approved by the United States
787 Food and Drug Administration, any material, compound, mixture,
788 or preparation, including its salts, isomers, esters, or ethers,
789 and salts of isomers, esters, or ethers, whenever the existence
790 of such salts is possible within any of the following specific
791 chemical designations, any compound containing a phenethylamine
792 structure, without a beta-keto group, and without a benzyl group
793 attached to the amine group, whether or not the compound is
794 further modified with or without substitution on the phenyl ring
795 to any extent with alkyl, alkylthio, nitro, alkoxy, thio,
796 halide, fused alkylenedioxy, fused furan, fused benzofuran,
797 fused dihydrofuran, or fused tetrahydropyran substituents,
798 whether or not further substituted on a ring to any extent, with
799 or without substitution at the alpha or beta position by any
800 alkyl substituent, with or without substitution at the nitrogen
801 atom, and with or without inclusion of the 2-amino nitrogen atom
802 in a cyclic structure, including, but not limited to:
803 a. 2C-B (4-Bromo-2,5-dimethoxyphenethylamine).
804 b. 2C-E (4-Ethyl-2,5-dimethoxyphenethylamine).
805 c. 2C-T-4 (4-Isopropylthio-2,5-dimethoxyphenethylamine).
806 d. 2C-C (4-Chloro-2,5-dimethoxyphenethylamine).
807 e. 2C-T (4-Methylthio-2,5-dimethoxyphenethylamine).
808 f. 2C-T-2 (4-Ethylthio-2,5-dimethoxyphenethylamine).
809 g. 2C-T-7 (4-(n)-Propylthio-2,5-dimethoxyphenethylamine).
810 h. 2C-I (4-Iodo-2,5-dimethoxyphenethylamine).
811 i. 2C-D (4-Methyl-2,5-dimethoxyphenethylamine).
812 j. 2C-H (2,5-Dimethoxyphenethylamine).
813 k. 2C-N (4-Nitro-2,5-dimethoxyphenethylamine).
814 l. 2C-P (4-(n)-Propyl-2,5-dimethoxyphenethylamine).
815 m. MDMA (3,4-Methylenedioxymethamphetamine).
816 n. MBDB (Methylbenzodioxolylbutanamine) or (3,4
817 Methylenedioxy-N-methylbutanamine).
818 o. MDA (3,4-Methylenedioxyamphetamine).
819 p. 2,5-Dimethoxyamphetamine.
820 q. Fluoroamphetamine.
821 r. Fluoromethamphetamine.
822 s. MDEA (3,4-Methylenedioxy-N-ethylamphetamine).
823 t. DOB (4-Bromo-2,5-dimethoxyamphetamine).
824 u. DOC (4-Chloro-2,5-dimethoxyamphetamine).
825 v. DOET (4-Ethyl-2,5-dimethoxyamphetamine).
826 w. DOI (4-Iodo-2,5-dimethoxyamphetamine).
827 x. DOM (4-Methyl-2,5-dimethoxyamphetamine).
828 y. PMA (4-Methoxyamphetamine).
829 z. N-Ethylamphetamine.
830 aa. 3,4-Methylenedioxy-N-hydroxyamphetamine.
831 bb. 5-Methoxy-3,4-methylenedioxyamphetamine.
832 cc. PMMA (4-Methoxymethamphetamine).
833 dd. N,N-Dimethylamphetamine.
834 ee. 3,4,5-Trimethoxyamphetamine.
835 ff. 4-APB (4-(2-Aminopropyl)benzofuran).
836 gg. 5-APB (5-(2-Aminopropyl)benzofuran).
837 hh. 6-APB (6-(2-Aminopropyl)benzofuran).
838 ii. 7-APB (7-(2-Aminopropyl)benzofuran).
839 jj. 4-APDB (4-(2-Aminopropyl)-2,3-dihydrobenzofuran).
840 kk. 5-APDB (5-(2-Aminopropyl)-2,3-dihydrobenzofuran).
841 ll. 6-APDB (6-(2-Aminopropyl)-2,3-dihydrobenzofuran).
842 mm. 7-APDB (7-(2-Aminopropyl)-2,3-dihydrobenzofuran).
843 nn. 4-MAPB (4-(2-Methylaminopropyl)benzofuran).
844 oo. 5-MAPB (5-(2-Methylaminopropyl)benzofuran).
845 pp. 6-MAPB (6-(2-Methylaminopropyl)benzofuran).
846 qq. 7-MAPB (7-(2-Methylaminopropyl)benzofuran).
847 rr. 5-EAPB (5-(2-Ethylaminopropyl)benzofuran).
848 ss. 5-MAPDB (5-(2-Methylaminopropyl)-2,3
849 dihydrobenzofuran),
850
851 which does not include phenethylamine, mescaline as described in
852 subparagraph 20., substituted cathinones as described in
853 subparagraph 191., N-Benzyl phenethylamine compounds as
854 described in subparagraph 193., or methamphetamine as described
855 in subparagraph (2)(c)5.
856 193. N-Benzyl Phenethylamine Compounds.—Unless specifically
857 excepted or unless listed in another schedule, or contained
858 within a pharmaceutical product approved by the United States
859 Food and Drug Administration, any material, compound, mixture,
860 or preparation, including its salts, isomers, esters, or ethers,
861 and salts of isomers, esters, or ethers, whenever the existence
862 of such salts is possible within any of the following specific
863 chemical designations, any compound containing a phenethylamine
864 structure without a beta-keto group, with substitution on the
865 nitrogen atom of the amino group with a benzyl substituent, with
866 or without substitution on the phenyl or benzyl ring to any
867 extent with alkyl, alkoxy, thio, alkylthio, halide, fused
868 alkylenedioxy, fused furan, fused benzofuran, or fused
869 tetrahydropyran substituents, whether or not further substituted
870 on a ring to any extent, with or without substitution at the
871 alpha position by any alkyl substituent, including, but not
872 limited to:
873 a. 25B-NBOMe (4-Bromo-2,5-dimethoxy-[N-(2
874 methoxybenzyl)]phenethylamine).
875 b. 25B-NBOH (4-Bromo-2,5-dimethoxy-[N-(2
876 hydroxybenzyl)]phenethylamine).
877 c. 25B-NBF (4-Bromo-2,5-dimethoxy-[N-(2
878 fluorobenzyl)]phenethylamine).
879 d. 25B-NBMD (4-Bromo-2,5-dimethoxy-[N-(2,3
880 methylenedioxybenzyl)]phenethylamine).
881 e. 25I-NBOMe (4-Iodo-2,5-dimethoxy-[N-(2
882 methoxybenzyl)]phenethylamine).
883 f. 25I-NBOH (4-Iodo-2,5-dimethoxy-[N-(2
884 hydroxybenzyl)]phenethylamine).
885 g. 25I-NBF (4-Iodo-2,5-dimethoxy-[N-(2
886 fluorobenzyl)]phenethylamine).
887 h. 25I-NBMD (4-Iodo-2,5-dimethoxy-[N-(2,3
888 methylenedioxybenzyl)]phenethylamine).
889 i. 25T2-NBOMe (4-Methylthio-2,5-dimethoxy-[N-(2
890 methoxybenzyl)]phenethylamine).
891 j. 25T4-NBOMe (4-Isopropylthio-2,5-dimethoxy-[N-(2
892 methoxybenzyl)]phenethylamine).
893 k. 25T7-NBOMe (4-(n)-Propylthio-2,5-dimethoxy-[N-(2
894 methoxybenzyl)]phenethylamine).
895 l. 25C-NBOMe (4-Chloro-2,5-dimethoxy-[N-(2
896 methoxybenzyl)]phenethylamine).
897 m. 25C-NBOH (4-Chloro-2,5-dimethoxy-[N-(2
898 hydroxybenzyl)]phenethylamine).
899 n. 25C-NBF (4-Chloro-2,5-dimethoxy-[N-(2
900 fluorobenzyl)]phenethylamine).
901 o. 25C-NBMD (4-Chloro-2,5-dimethoxy-[N-(2,3
902 methylenedioxybenzyl)]phenethylamine).
903 p. 25H-NBOMe (2,5-Dimethoxy-[N-(2
904 methoxybenzyl)]phenethylamine).
905 q. 25H-NBOH (2,5-Dimethoxy-[N-(2
906 hydroxybenzyl)]phenethylamine).
907 r. 25H-NBF (2,5-Dimethoxy-[N-(2
908 fluorobenzyl)]phenethylamine).
909 s. 25D-NBOMe (4-Methyl-2,5-dimethoxy-[N-(2
910 methoxybenzyl)]phenethylamine),
911
912 which does not include substituted cathinones as described in
913 subparagraph 191.
914 194. Substituted Tryptamines.—Unless specifically excepted
915 or unless listed in another schedule, or contained within a
916 pharmaceutical product approved by the United States Food and
917 Drug Administration, any material, compound, mixture, or
918 preparation containing a 2-(1H-indol-3-yl)ethanamine, for
919 example tryptamine, structure with or without mono- or di
920 substitution of the amine nitrogen with alkyl or alkenyl groups,
921 or by inclusion of the amino nitrogen atom in a cyclic
922 structure, whether or not substituted at the alpha position with
923 an alkyl group, whether or not substituted on the indole ring to
924 any extent with any alkyl, alkoxy, halo, hydroxyl, or acetoxy
925 groups, including, but not limited to:
926 a. Alpha-Ethyltryptamine.
927 b. Bufotenine.
928 c. DET (Diethyltryptamine).
929 d. DMT (Dimethyltryptamine).
930 e. MET (N-Methyl-N-ethyltryptamine).
931 f. DALT (N,N-Diallyltryptamine).
932 g. EiPT (N-Ethyl-N-isopropyltryptamine).
933 h. MiPT (N-Methyl-N-isopropyltryptamine).
934 i. 5-Hydroxy-AMT (5-Hydroxy-alpha-methyltryptamine).
935 j. 5-Hydroxy-N-methyltryptamine.
936 k. 5-MeO-MiPT (5-Methoxy-N-methyl-N-isopropyltryptamine).
937 l. 5-MeO-AMT (5-Methoxy-alpha-methyltryptamine).
938 m. Methyltryptamine.
939 n. 5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine).
940 o. 5-Me-DMT (5-Methyl-N,N-dimethyltryptamine).
941 p. 5-MeO-DiPT (5-Methoxy-N,N-Diisopropyltryptamine).
942 q. DiPT (N,N-Diisopropyltryptamine).
943 r. DPT (N,N-Dipropyltryptamine).
944 s. 4-Hydroxy-DiPT (4-Hydroxy-N,N-diisopropyltryptamine).
945 t. 5-MeO-DALT (5-Methoxy-N,N-Diallyltryptamine).
946 u. 4-AcO-DMT (4-Acetoxy-N,N-dimethyltryptamine).
947 v. 4-AcO-DiPT (4-Acetoxy-N,N-diisopropyltryptamine).
948 w. 4-Hydroxy-DET (4-Hydroxy-N,N-diethyltryptamine).
949 x. 4-Hydroxy-MET (4-Hydroxy-N-methyl-N-ethyltryptamine).
950 y. 4-Hydroxy-MiPT (4-Hydroxy-N-methyl-N
951 isopropyltryptamine).
952 z. Methyl-alpha-ethyltryptamine.
953 aa. Bromo-DALT (Bromo-N,N-diallyltryptamine),
954
955 which does not include tryptamine, psilocyn as described in
956 subparagraph 34., or psilocybin as described in subparagraph 33.
957 195. Substituted Phenylcyclohexylamines.—Unless
958 specifically excepted or unless listed in another schedule, or
959 contained within a pharmaceutical product approved by the United
960 States Food and Drug Administration, any material, compound,
961 mixture, or preparation containing a phenylcyclohexylamine
962 structure, with or without any substitution on the phenyl ring,
963 any substitution on the cyclohexyl ring, any replacement of the
964 phenyl ring with a thiophenyl or benzothiophenyl ring, with or
965 without substitution on the amine with alkyl, dialkyl, or alkoxy
966 substituents, inclusion of the nitrogen in a cyclic structure,
967 or any combination of the above, including, but not limited to:
968 a. BTCP (Benzothiophenylcyclohexylpiperidine) or BCP
969 (Benocyclidine).
970 b. PCE (N-Ethyl-1-phenylcyclohexylamine)(Ethylamine analog
971 of phencyclidine).
972 c. PCPY (N-(1-Phenylcyclohexyl)-pyrrolidine)(Pyrrolidine
973 analog of phencyclidine).
974 d. PCPr (Phenylcyclohexylpropylamine).
975 e. TCP (1-[1-(2-Thienyl)-cyclohexyl]-piperidine)(Thiophene
976 analog of phencyclidine).
977 f. PCEEA (Phenylcyclohexyl(ethoxyethylamine)).
978 g. PCMPA (Phenylcyclohexyl(methoxypropylamine)).
979 h. Methoxetamine.
980 i. 3-Methoxy-PCE ((3-Methoxyphenyl)cyclohexylethylamine).
981 j. Bromo-PCP ((Bromophenyl)cyclohexylpiperidine).
982 k. Chloro-PCP ((Chlorophenyl)cyclohexylpiperidine).
983 l. Fluoro-PCP ((Fluorophenyl)cyclohexylpiperidine).
984 m. Hydroxy-PCP ((Hydroxyphenyl)cyclohexylpiperidine).
985 n. Methoxy-PCP ((Methoxyphenyl)cyclohexylpiperidine).
986 o. Methyl-PCP ((Methylphenyl)cyclohexylpiperidine).
987 p. Nitro-PCP ((Nitrophenyl)cyclohexylpiperidine).
988 q. Oxo-PCP ((Oxophenyl)cyclohexylpiperidine).
989 r. Amino-PCP ((Aminophenyl)cyclohexylpiperidine).
990 196. W-15, 4-chloro-N-[1-(2-phenylethyl)-2
991 piperidinylidene]-benzenesulfonamide.
992 197. W-18, 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2
993 piperidinylidene]-benzenesulfonamide.
994 198. AH-7921, 3,4-dichloro-N-[[1
995 (dimethylamino)cyclohexyl]methyl]-benzamide.
996 199. U47700, trans-3,4-dichloro-N-[2
997 (dimethylamino)cyclohexyl]-N-methyl-benzamide.
998 200. MT-45, 1-cyclohexyl-4-(1,2-diphenylethyl)-piperazine,
999 dihydrochloride.
1000 Section 4. Paragraph (i) of subsection (1) of section
1001 893.13, Florida Statutes, is amended to read:
1002 893.13 Prohibited acts; penalties.—
1003 (1)
1004 (i) Except as authorized by this chapter, a person commits
1005 a felony of the first degree, punishable as provided in s.
1006 775.082, s. 775.083, or s. 775.084, and must be sentenced to a
1007 mandatory minimum term of imprisonment of 3 years, if:
1008 1. The person sells, manufactures, or delivers, or
1009 possesses with intent to sell, manufacture, or deliver, any of
1010 the following:
1011 a. Alfentanil, as described in s. 893.03(2)(b)1.;
1012 b. Carfentanil, as described in s. 893.03(2)(b)6.;
1013 c. Fentanyl, as described in s. 893.03(2)(b)9.;
1014 d. Sufentanil, as described in s. 893.03(2)(b)30.;
1015 e. A fentanyl derivative, as described in s.
1016 893.03(1)(a)63.;
1017 f. Xylazine, as described in s. 893.03(1)(c)37.;
1018 g.f. A controlled substance analog, as described in s.
1019 893.0356, of any substance described in sub-subparagraphs a.-f.
1020 sub-subparagraphs a.-e.; or
1021 h.g. A mixture containing any substance described in sub
1022 subparagraphs a.-g. sub-subparagraphs a.-f.; and
1023 2. The substance or mixture listed in subparagraph 1. is in
1024 a form that resembles, or is mixed, granulated, absorbed, spray
1025 dried, or aerosolized as or onto, coated on, in whole or in
1026 part, or solubilized with or into, a product, when such product
1027 or its packaging further has at least one of the following
1028 attributes:
1029 a. Resembles the trade dress of a branded food product,
1030 consumer food product, or logo food product;
1031 b. Incorporates an actual or fake registered copyright,
1032 service mark, or trademark;
1033 c. Resembles candy, cereal, a gummy, a vitamin, or a
1034 chewable product, such as a gum or gelatin-based product; or
1035 d. Contains a cartoon character imprint.
1036 Section 5. Paragraph (c) of subsection (1) of section
1037 893.135, Florida Statutes, is amended to read:
1038 893.135 Trafficking; mandatory sentences; suspension or
1039 reduction of sentences; conspiracy to engage in trafficking.—
1040 (1) Except as authorized in this chapter or in chapter 499
1041 and notwithstanding the provisions of s. 893.13:
1042 (c)1. A person who knowingly sells, purchases,
1043 manufactures, delivers, or brings into this state, or who is
1044 knowingly in actual or constructive possession of, 4 grams or
1045 more of any morphine, opium, hydromorphone, or any salt,
1046 derivative, isomer, or salt of an isomer thereof, including
1047 heroin, as described in s. 893.03(1)(b), (2)(a), (3)(c)3., or
1048 (3)(c)4., or 4 grams or more of any mixture containing any such
1049 substance, but less than 30 kilograms of such substance or
1050 mixture, commits a felony of the first degree, which felony
1051 shall be known as “trafficking in illegal drugs,” punishable as
1052 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1053 quantity involved:
1054 a. Is 4 grams or more, but less than 14 grams, such person
1055 shall be sentenced to a mandatory minimum term of imprisonment
1056 of 3 years and shall be ordered to pay a fine of $50,000.
1057 b. Is 14 grams or more, but less than 28 grams, such person
1058 shall be sentenced to a mandatory minimum term of imprisonment
1059 of 15 years and shall be ordered to pay a fine of $100,000.
1060 c. Is 28 grams or more, but less than 30 kilograms, such
1061 person shall be sentenced to a mandatory minimum term of
1062 imprisonment of 25 years and shall be ordered to pay a fine of
1063 $500,000.
1064 2. A person who knowingly sells, purchases, manufactures,
1065 delivers, or brings into this state, or who is knowingly in
1066 actual or constructive possession of, 28 grams or more of
1067 hydrocodone, as described in s. 893.03(2)(a)1.k., codeine, as
1068 described in s. 893.03(2)(a)1.g., or any salt thereof, or 28
1069 grams or more of any mixture containing any such substance,
1070 commits a felony of the first degree, which felony shall be
1071 known as “trafficking in hydrocodone,” punishable as provided in
1072 s. 775.082, s. 775.083, or s. 775.084. If the quantity involved:
1073 a. Is 28 grams or more, but less than 50 grams, such person
1074 shall be sentenced to a mandatory minimum term of imprisonment
1075 of 3 years and shall be ordered to pay a fine of $50,000.
1076 b. Is 50 grams or more, but less than 100 grams, such
1077 person shall be sentenced to a mandatory minimum term of
1078 imprisonment of 7 years and shall be ordered to pay a fine of
1079 $100,000.
1080 c. Is 100 grams or more, but less than 300 grams, such
1081 person shall be sentenced to a mandatory minimum term of
1082 imprisonment of 15 years and shall be ordered to pay a fine of
1083 $500,000.
1084 d. Is 300 grams or more, but less than 30 kilograms, such
1085 person shall be sentenced to a mandatory minimum term of
1086 imprisonment of 25 years and shall be ordered to pay a fine of
1087 $750,000.
1088 3. A person who knowingly sells, purchases, manufactures,
1089 delivers, or brings into this state, or who is knowingly in
1090 actual or constructive possession of, 7 grams or more of
1091 oxycodone, as described in s. 893.03(2)(a)1.q., or any salt
1092 thereof, or 7 grams or more of any mixture containing any such
1093 substance, commits a felony of the first degree, which felony
1094 shall be known as “trafficking in oxycodone,” punishable as
1095 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1096 quantity involved:
1097 a. Is 7 grams or more, but less than 14 grams, such person
1098 shall be sentenced to a mandatory minimum term of imprisonment
1099 of 3 years and shall be ordered to pay a fine of $50,000.
1100 b. Is 14 grams or more, but less than 25 grams, such person
1101 shall be sentenced to a mandatory minimum term of imprisonment
1102 of 7 years and shall be ordered to pay a fine of $100,000.
1103 c. Is 25 grams or more, but less than 100 grams, such
1104 person shall be sentenced to a mandatory minimum term of
1105 imprisonment of 15 years and shall be ordered to pay a fine of
1106 $500,000.
1107 d. Is 100 grams or more, but less than 30 kilograms, such
1108 person shall be sentenced to a mandatory minimum term of
1109 imprisonment of 25 years and shall be ordered to pay a fine of
1110 $750,000.
1111 4.a. A person who knowingly sells, purchases, manufactures,
1112 delivers, or brings into this state, or who is knowingly in
1113 actual or constructive possession of, 4 grams or more of:
1114 (I) Alfentanil, as described in s. 893.03(2)(b)1.;
1115 (II) Carfentanil, as described in s. 893.03(2)(b)6.;
1116 (III) Fentanyl, as described in s. 893.03(2)(b)9.;
1117 (IV) Sufentanil, as described in s. 893.03(2)(b)30.;
1118 (V) A fentanyl derivative, as described in s.
1119 893.03(1)(a)63.;
1120 (VI) A controlled substance analog, as described in s.
1121 893.0356, of any substance described in sub-sub-subparagraphs
1122 (I)-(V); or
1123 (VII) A mixture containing any substance described in sub
1124 sub-subparagraphs (I)-(VI),
1125
1126 commits a felony of the first degree, which felony shall be
1127 known as “trafficking in dangerous fentanyl or fentanyl
1128 analogues,” punishable as provided in s. 775.082, s. 775.083, or
1129 s. 775.084.
1130 b. If the quantity involved under sub-subparagraph a.:
1131 (I) Is 4 grams or more, but less than 14 grams, such person
1132 shall be sentenced to a mandatory minimum term of imprisonment
1133 of 7 years, and shall be ordered to pay a fine of $50,000.
1134 (II) Is 14 grams or more, but less than 28 grams, such
1135 person shall be sentenced to a mandatory minimum term of
1136 imprisonment of 20 years, and shall be ordered to pay a fine of
1137 $100,000.
1138 (III) Is 28 grams or more, such person shall be sentenced
1139 to a mandatory minimum term of imprisonment of 25 years, and
1140 shall be ordered to pay a fine of $500,000.
1141 c. A person 18 years of age or older who violates sub
1142 subparagraph a. by knowingly selling or delivering to a minor at
1143 least 4 grams of a substance or mixture listed in sub
1144 subparagraph a. shall be sentenced to a mandatory minimum term
1145 of not less than 25 years and not exceeding life imprisonment,
1146 and shall be ordered to pay a fine of $1 million if the
1147 substance or mixture listed in sub-subparagraph a. is in a form
1148 that resembles, or is mixed, granulated, absorbed, spray-dried,
1149 or aerosolized as or onto, coated on, in whole or in part, or
1150 solubilized with or into, a product, when such product or its
1151 packaging further has at least one of the following attributes:
1152 (I) Resembles the trade dress of a branded food product,
1153 consumer food product, or logo food product;
1154 (II) Incorporates an actual or fake registered copyright,
1155 service mark, or trademark;
1156 (III) Resembles candy, cereal, a gummy, a vitamin, or a
1157 chewable product, such as a gum or gelatin-based product; or
1158 (IV) Contains a cartoon character imprint.
1159 5. A person who knowingly sells, purchases, manufactures,
1160 delivers, or brings into this state, or who is knowingly in
1161 actual or constructive possession of, 30 kilograms or more of
1162 any morphine, opium, oxycodone, hydrocodone, codeine,
1163 hydromorphone, or any salt, derivative, isomer, or salt of an
1164 isomer thereof, including heroin, as described in s.
1165 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or 30 kilograms or
1166 more of any mixture containing any such substance, commits the
1167 first degree felony of trafficking in illegal drugs. A person
1168 who has been convicted of the first degree felony of trafficking
1169 in illegal drugs under this subparagraph shall be punished by
1170 life imprisonment and is ineligible for any form of
1171 discretionary early release except pardon or executive clemency
1172 or conditional medical release under s. 947.149. However, if the
1173 court determines that, in addition to committing any act
1174 specified in this paragraph:
1175 a. The person intentionally killed an individual or
1176 counseled, commanded, induced, procured, or caused the
1177 intentional killing of an individual and such killing was the
1178 result; or
1179 b. The person’s conduct in committing that act led to a
1180 natural, though not inevitable, lethal result,
1181
1182 such person commits the capital felony of trafficking in illegal
1183 drugs, punishable as provided in ss. 775.082 and 921.142. A
1184 person sentenced for a capital felony under this paragraph shall
1185 also be sentenced to pay the maximum fine provided under
1186 subparagraph 1.
1187 6. A person who knowingly brings into this state 60
1188 kilograms or more of any morphine, opium, oxycodone,
1189 hydrocodone, codeine, hydromorphone, or any salt, derivative,
1190 isomer, or salt of an isomer thereof, including heroin, as
1191 described in s. 893.03(1)(b), (2)(a), (3)(c)3., or (3)(c)4., or
1192 60 kilograms or more of any mixture containing any such
1193 substance, and who knows that the probable result of such
1194 importation would be the death of a person, commits capital
1195 importation of illegal drugs, a capital felony punishable as
1196 provided in ss. 775.082 and 921.142. A person sentenced for a
1197 capital felony under this paragraph shall also be sentenced to
1198 pay the maximum fine provided under subparagraph 1.
1199 7. A person who knowingly sells, purchases, manufactures,
1200 delivers, or brings into this state, or who is knowingly in
1201 actual or constructive possession of, 28 grams or more of
1202 xylazine, as described in s. 893.03(1)(c)37., or any salt
1203 thereof, or 28 grams or more of any mixture containing any such
1204 substance, commits a felony of the first degree, which felony
1205 shall be known as “trafficking in xylazine,” punishable as
1206 provided in s. 775.082, s. 775.083, or s. 775.084. If the
1207 quantity involved:
1208 a. Is 28 grams or more, but less than 100 grams, such
1209 person shall be sentenced to a mandatory minimum term of
1210 imprisonment of 3 years and shall be ordered to pay a fine of
1211 $50,000.
1212 b. Is 100 grams or more, but less than 200 grams, such
1213 person shall be sentenced to a mandatory minimum term of
1214 imprisonment of 7 years and shall be ordered to pay a fine of
1215 $100,000.
1216 c. Is 200 grams or more, such person shall be sentenced to
1217 a mandatory minimum term of imprisonment of 25 years and shall
1218 be ordered to pay a fine of $500,000.
1219 Section 6. Except as otherwise expressly provided in this
1220 act and except for this section, which shall take effect upon
1221 this act becoming a law, this act shall take effect October 1,
1222 2026.
1223
1224 ================= T I T L E A M E N D M E N T ================
1225 And the title is amended as follows:
1226 Delete everything before the enacting clause
1227 and insert:
1228 A bill to be entitled
1229 An act relating to intoxicating substances; providing
1230 a short title; creating s. 569.216, F.S.; prohibiting
1231 tobacco or nicotine dealers, or their agents or
1232 employees, from possessing, selling, possessing with
1233 intent to sell, delivering, or giving, directly or
1234 indirectly, nitrous oxide on or from the dealer’s
1235 licensed premises; providing criminal penalties;
1236 providing applicability; providing an exception;
1237 requiring the Department of Business and Professional
1238 Regulation to adopt rules; amending s. 893.03, F.S.;
1239 excepting from the list of Schedule I controlled
1240 substances certain xylazine animal drug products
1241 approved by the United States Food and Drug
1242 Administration and used for certain purposes; amending
1243 s. 893.13, F.S.; providing criminal penalties and
1244 requiring a mandatory minimum term of imprisonment if
1245 a person sells, manufactures, or delivers or possesses
1246 with intent to sell, manufacture, or deliver xylazine;
1247 amending s. 893.135, F.S.; creating the offense of
1248 trafficking in xylazine; providing criminal penalties
1249 and requiring a mandatory minimum term of imprisonment
1250 and fines based on the quantity of the controlled
1251 substance involved in the offense; providing effective
1252 dates.